How does Staphylococcus aureus escape the bloodstream?

Trends in Microbiology

Volumn 19, Issue 4, 2011, Pages 184-190

  Edwards, Andrew M ^a   Massey, Ruth C ^a  

^a University of Bath   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABSCESS; BACTEREMIA; BACTERIAL ARTHRITIS; BACTERIAL ENDOCARDITIS; BACTERIUM ADHERENCE; BLOOD FLOW; ENDOTHELIUM; MORBIDITY; MORTALITY; NONHUMAN; OSTEOMYELITIS; PARACYTOSIS; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; SECONDARY INFECTION; STAPHYLOCOCCUS AUREUS; TRANSCYTOSIS;

ABSCESS; ARTHRITIS, INFECTIOUS; BACTEREMIA; CAPILLARY PERMEABILITY; ENDOCARDITIS, BACTERIAL; HUMANS; MODELS, BIOLOGICAL; OSTEOMYELITIS; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS AUREUS;

EID: 79953277728     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tim.2010.12.005     Document Type: Review

References (61)

1. Lowy F.D. Staphylococcus aureus infections. N. Engl. J. Med. 1998, 339:520-532.
2. Kluytmans J., et al. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin. Microbiol. Rev. 1997, 10:505-520.
3. Nguyen H.B., et al. Severe sepsis and septic shock: review of the literature and emergency department management guidelines. Ann. Emerg. Med. 2006, 48:28-54.
4. Vincent J.L., et al. Sepsis in European intensive care units: results of the SOAP study. Crit. Care Med. 2006, 34:344-353.
5. Fowler V.G., et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch. Intern. Med. 2003, 163:2066-2072.
6. Lemichez, et al. Breaking the wall: targeting of the endothelium by pathogenic bacteria. Nat. Rev. Microbiol. 2010, 8:93-104.
7. Kerdudou S., et al. Fibronectin-binding proteins contribute to the adherence of Staphylococcus aureus to intact endothelium in vivo. Thomb. Haemost. 2006, 96:183-189.
8. Cheng A.G., et al. Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues. FASEB J. 2009, 23:3393-3404.
9. Chavakis T., et al. Staphylococcus aureus extracellular adherence protein serves as anti-inflammatory factor by inhibiting the recruitment of host leukocytes. Nat. Med. 2002, 8:687-693.
10. Harraghy N., et al. The adhesive and immunomodulating properties of the multifunctional Staphylococcus aureus protein Eap. Microbiology 2003, 149:2701-2707.
11. Chavakis T., et al. Staphylococcus aureus interactions with the endothelium: the role of bacterial " secretable expanded repertoire adhesive molecules" (SERAM) in disturbing host defense systems. Thromb. Haemost. 2005, 94:278-285.
12. Mattsson E., et al. Staphylococcal peptidoglycan initiates an inflammatory response and procoagulant activity in human vascular endothelial cells: a comparison with highly purified lipoteichoic acid and TSST-1. FEMS Immunol. Med. Microbiol. 2008, 52:110-117.
13. Heying R., et al. Contribution of (sub)domains of Staphylococcus aureus fibronectin-binding protein to the proinflammatory and procoagulant response of human vascular endothelial cells. Thomb. Haemost. 2009, 101:495-504.
14. Weidenmaier C., et al. Lack of wall teichoic acids in Staphylococcus aureus leads to reduced interactions with endothelial cells and to attenuated virulence in a rabbit model of endocarditis. J. Infect. Dis. 2005, 191:1771-1777.
15. Weidenmaier C., et al. Differential roles of sortase-anchored surface proteins and wall teichoic acid in Staphylococcus aureus nasal colonization. Int. J. Med. Microbiol. 2008, 298:505-513.
16. Sheen T.R., et al. Penetration of the blood-brain barrier by Staphylococcus aureus: contribution of membrane-anchored lipoteichoic acid. J. Mol. Med. 2010, 88:633-639.
17. Norman M.U., et al. Molecular mechanisms involved in vascular interactions of the Lyme disease pathogen in a living host. PLoS Pathog. 2008, 4:e1000169.
18. Mikaty G., et al. Extracellular bacterial pathogen induces host cell surface reorganization to resist shear stress. PLoS Pathog. 2009, 5:e1000314.
19. Huang S.H., et al. Bacterial penetration across the blood-brain barrier during the development of neonatal meningitis. Microbes Infect. 2000, 2:1237-1244.
20. Sinha B., Herrmann M. Mechanism and consequences of invasion of endothelial cells by Staphylococcus aureus. Thomb. Haemost. 2005, 94:266-277.
21. Que Y.A., et al. Fibrinogen and fibronectin-binding cooperate for valve infection and invasion in Staphylococcus aureus experimental endocarditis. J. Exp. Med. 2005, 201:1627-1635.
22. Bingham R.J., et al. Crystal structures of fibronectin-binding sites from Staphylococcus aureus FnBPA in complex with Fn domains. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:12254-12258.
23. Edwards A.M., et al. Staphylococcus aureus host cell invasion and virulence in sepsis is facilitated by the multiple repeats within FnBPA. PLoS Pathog. 2010, 6:e1000964.
24. Giese B., et al. Expression of δ-toxin by Staphylococcus aureus mediates escape from phago-endosomes of human epithelial and endothelial cells in the presence of β-toxin. Cell. Microbiol. 2011, 13:316-329.
25. Sinha B., Fraunholz M. Staphylococcus aureus host cell invasion and post-invasion events. Int. J. Med. Microbiol. 2010, 300:170-175.
26. Coureuil M., et al. Meningococcal type IV pili recruit the polarity complex to cross the brain endothelium. Science 2009, 325:83-87.
27. Pezzicoli A., et al. Pilus backbone contributes to group B Streptococcus paracellular translocation through epithelial cells. J. Infect. Dis. 2008, 198:890-898.
28. Ohnemus U., et al. Regulation of epidermal tight-junctions (TJ) during infection with exfoliative toxin-negative Staphylococcus strains. J. Invest. Dermatol. 2008, 128:906-916.
29. Vandenbroucke E., et al. Regulation of endothelial junctional permeability. Ann. N.Y. Acad. Sci. 2008, 1123:134-145.
30. Jonkam C.C., et al. Cardiovascular collapse and vascular permeability changes in an ovine model of methicillin-resistant Staphylococcus aureus sepsis. Shock 2009, 32:621-625.
31. Scriba T.J., et al. The Staphylococcus aureus Eap protein activates expression of proinflammatory cytokines. Infect. Immun. 2008, 76:2164-2168.
32. Flannagan R.S., et al. Antimicrobial mechanisms of phagocytes and bacterial evasion strategies. Nat. Rev. Microbiol. 2009, 7:355-366.
33. Vazquez-Torres A., et al. Extraintestinal dissemination of Salmonella by CD18-expressing phagocytes. Nature 1999, 401:804-808.
34. Gieffers J., et al. Phagocytes transmit Chlamydia pneumoniae from the lungs to the vasculature. Eur. Respir. J. 2004, 23:506-510.
35. Bar-Haim E., et al. Interrelationship between dendritic cell trafficking and Francisella tularensis dissemination following airway infection. PLoS Pathog. 2008, 4:e1000211.
36. Charlier C., et al. Evidence of a role for monocytes in dissemination and brain invasion by Cryptococcus neoformans. Infect. Immun. 2009, 77:120-127.
37. Newton H.J., et al. Molecular pathogenesis of infections caused by Legionella pneumophila. Clin. Microbiol. Rev. 2010, 23:274-298.
38. Voyich J.M., et al. Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J. Immunol. 2005, 175:3907-3919.
39. Anwar S., et al. The rise and rise of Staphylococcus aureus: laughing in the face of granulocytes. Clin. Exp. Immunol. 2009, 157:216-224.
40. Rogers D.E., Tompsett R. The survival of staphylococci within human leukocytes. J. Exp. Med. 1952, 95:209-230.
41. Kubica M., et al. A potential new pathway for Staphylococcus aureus dissemination: the silent survival of S. aureus phagocytosed by human monocyte-derived macrophages. PLoS One 2008, 3:e1409.
42. Tuchscherr L., et al. Staphylococcus aureus small-colony variants are adapted phenotypes for intracellular persistence. J. Infect. Dis. 2010, 202:1031-1040.
43. Koziel J., et al. Phagocytosis of Staphylococcus aureus by macrophages exerts cytoprotective effects manifested by the upregulation of antiapoptotic factors. PLoS One 2009, 4:e5210.
44. Banga S., et al. Legionella pneumophila inhibits macrophage apoptosis by targeting pro-death members of the Bcl2 protein family. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:5121-5126.
45. Voyich J.M., et al. Analysis of Staphylococcus aureus gene expression during PMN phagocytosis. Methods Mol. Biol. 2008, 431:109-122.
46. Mylonakis E., Calderwood S.B. Infective endocarditis in adults. N. Engl. J. Med. 2001, 345:1318-1330.
47. Fowler V.G., et al. Staphylococcus aureus endocarditis: a consequence of medical progress. J. Am. Med. Assoc. 2005, 293:3012-3021.
48. Beynon R.P., et al. Infective endocarditis. Br. Med. J. 2006, 333:334-339.
49. Prendergast B.D., Tornos P. Surgery for infective endocarditis: who and when?. Circulation 2010, 121:1141-1152.
50. Heying R., et al. Fibronectin-binding proteins and clumping factor A in Staphylococcus aureus experimental endocarditis: FnBpA is sufficient to activate human endothelial cells. Thomb. Haemost. 2007, 97:617-626.
51. Breitenstein A., et al. Tissue factor and cardiovascular disease: quo vadis?. Circ. J. 2010, 74:3-12.
52. Kerrigan S.W., et al. Molecular basis for Staphylococcus aureus-mediated platelet aggregate formation under arterial shear in vitro. Arterioscler. Thromb. Vasc. Biol. 2008, 28:335-340.
53. Piroth L., et al. The fibrinogen- and fibronectin-binding domains of Staphylococcus aureus fibronectin-binding protein A synergistically promote endothelial invasion and experimental endocarditis. Infect. Immun. 2008, 76:3824-3831.
54. Chorianopoulos E., et al. The role of endothelial cell biology in endocarditis. Cell Tissue Res. 2009, 335:153-163.
55. Gordon R.J., Lowy F.D. Pathogenesis of methicillin-resistant Staphylococcus aureus infection. Clin. Infect. Dis. 2008, 46:S350-359.
56. Jaffe A.B., Hall A. Rho GTPases: biochemistry and biology. Annu. Rev. Cell Dev. Biol. 2005, 21:247-269.
57. Boyer L., et al. Induction of transient macroapertures in endothelial cells through RhoA inhibition by Staphylococcus aureus factors. J. Cell Biol. 2006, 173:809-819.
58. Franke G.C., et al. Epidemiology, variable genetic organization and regulation of the EDIN-B toxin in Staphylococcus aureus from bacteraemic patients. Microbiology 2010, 156:860-872.
59. Munro P., et al. The Staphylococcus aureus epidermal cell differentiation inhibitor toxin promotes formation of infection foci in a mouse model of bacteremia. Infect. Immun. 2010, 78:3404-3411.
60. Holtfreter S., et al. Clonal distribution of superantigen genes in clinical Staphylococcus aureus isolates. J. Clin. Microbiol. 2007, 45:2669-2680.
61. Josefsson E., et al. Fibrinogen binding sites P336 and Y338 of clumping factor A are crucial for Staphylococcus aureus virulence. PLoS One 2008, 3:e2206.